HEMABATE (carboprost tromethamine)
ABORTION·+1
PHARMACIA/UPJHN
Indication
Abortion
Abortion, in the context of a pharmacotherapeutic indication, refers to the intentional termination of an intrauterine pregnancy prior to fetal viability, specifically through induced medical or medication-assisted means. Read more about Abortion
45 drugs 35 manufacturers
Drugs that treat it
Common Abortion therapies.
PROSTIN E2 VAGINAL SUPPOSITORY (dinoprostone)
BENIGN HYDATIDIFORM MOLE·+2
PHARMACIA/UPJHN
OXYTOCIN
INCOMPLETE ABORTION·+3
APP PHARMACEUTI
PITOCIN (oxytocin)
INCOMPLETE ABORTION·+3
JHP PHARMACEUTI
OXYTOCIN
ABORTIFACIENTS·INCOMPLETE ABORTION·+3
APP/NOVAPLUS
OXYTOCIN
INCOMPLETE ABORTION·+3
JHP PHARMACEUTI
OXYTOCIN
INCOMPLETE ABORTION·+3
WEST-WARD,INC.
OXYTOCIN-0.9% NACL (oxytocin in 0.9 % sodium chloride)
ABORTIFACIENTS·INCOMPLETE ABORTION·+3
QUVA PHARMA, IN
OXYTOCIN-LACTATED RINGERS (oxytocin/Ringer's solution,lactated)
INCOMPLETE ABORTION·+3
SCA PHARMACEUTI
Filter & compare in the drug finder →Opens the drug finder with Abortion preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAbortion, in the context of a pharmacotherapeutic indication, refers to the intentional termination of an intrauterine pregnancy prior to fetal viability, specifically through induced medical or medication-assisted means.
This clinical intervention directly affects the female reproductive system in pregnant individuals, indicated either electively or therapeutically due to maternal medical conditions or severe fetal abnormalities.
Pathophysiologically and clinically, medication-induced abortion relies on pharmacologic agents—typically antiprogestins and synthetic prostaglandins—to halt gestational development, promote decidual necrosis, soften and dilate the cervix, and stimulate myometrial contractions to expel embryonic or fetal tissue and gestational sac components from the uterus.
- nih.gov
Abortion, in the context of a pharmacotherapeutic indication, refers to the intentional termination of an intrauterine pregnancy prior to fetal viability, specifically through induced medical or medication-assisted means
- nih.gov
Abortion, in the context of a pharmacotherapeutic indication, refers to the intentional termination of an intrauterine pregnancy prior to fetal viability, specifically through induced medical or medication-assisted means Pathophysiologically and clinically, medication-induced abortion relies on pharmacologic agents—typically antiprogestins and synthetic prostaglandins—to halt gestational development, promote decidual necrosis, soften and dilate the cervix, and stimulate myometrial contractions t...
- nih.gov
This clinical intervention directly affects the female reproductive system in pregnant individuals, indicated either electively or therapeutically due to maternal medical conditions or severe fetal abnormalities Pathophysiologically and clinically, medication-induced abortion relies on pharmacologic agents—typically antiprogestins and synthetic prostaglandins—to halt gestational development, promote decidual necrosis, soften and dilate the cervix, and stimulate myometrial contractions to expel e...
- nih.gov
Pathophysiologically and clinically, medication-induced abortion relies on pharmacologic agents—typically antiprogestins and synthetic prostaglandins—to halt gestational development, promote decidual necrosis, soften and dilate the cervix, and stimulate myometrial contractions to expel embryonic or fetal tissue and gestational sac components from the uterus
Personalize your experience
Follow Abortion and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.